{"title_page": "Enallylpropymal", "text_new": "{{Drugbox\n| Watchedfields = changed\n| verifiedrevid = 424666646\n| IUPAC_name = (''RS'')-1-Methyl-5-allyl-5-isopropyl-1,3-diazinane-2,4,6-trione\n| image = Enallylpropymal.png\n| width = 150\n| chirality = [[Racemic mixture]]\n| drug_name = \n<!--Clinical data-->\n| tradename =  \n| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->\n| pregnancy_US = <!-- A / B            / C / D / X -->\n| pregnancy_category =  \n| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->\n| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->\n| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->\n| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->\n| legal_status =  \n| routes_of_administration =\n\n<!--Pharmacokinetic data-->\n| bioavailability =  \n| protein_bound =  \n| metabolism =  \n| elimination_half-life =  \n| excretion =\n\n<!--Identifiers-->\n| CAS_number_Ref = {{cascite|correct|??}}\n| CAS_number = 1861-21-8\n| UNII_Ref = {{fdacite|correct|FDA}}\n| UNII = 17BT2X209M\n| ATC_prefix = none\n| ATC_suffix =  \n| DrugBank_Ref = {{drugbankcite|correct|drugbank}}\n| DrugBank =  \n| ChemSpiderID = 86329\n\n<!--Chemical data-->\n| C=11 | H=16 | N=2 | O=3 \n| molecular_weight = 224.256 g/mol\n| smiles = O=C1NC(=O)N(C)C(=O)C1(C(C)C)CC=C\n| synonyms = Enallylpropymal\n|  PubChem = 95636\n|  StdInChI = 1S/C11H16N2O3/c1-5-6-11(7(2)3)8(14)12-10(16)13(4)9(11)15/h5,7H,1,6H2,2-4H3,(H,12,14,16)\n|  StdInChIKey = AXJXURWWUFZZKN-UHFFFAOYSA-N\n\n}}\n\n'''Enallylpropymal''' ('''Narconumal''') is a [[barbiturate]] derivative developed by Hoffman la Roche in the 1930s.<ref>US Patent 2072829</ref> It has [[sedative]] and [[hypnotic]] effects and is considered to have a moderate abuse potential.<ref>Eddy NB, Halbach H, Isbell H, Seevers MH. Drug dependence: Its significance and characteristics. ''Bulletin of the World Health Organization''. 1965;32:721-733.</ref>\n\n== References ==\n{{reflist}}\n\n{{Sedatives}}\n{{GABAAR PAMs}}\n\n[[Category:Barbiturates]]\n[[Category:Allyl compounds]]\n[[Category:GABAA receptor positive allosteric modulators]]\n\n\n{{sedative-stub}}\n", "text_old": "{{Drugbox\n| Watchedfields = changed\n| verifiedrevid = 424666646\n| IUPAC_name = (''RS'')-1-Methyl-5-allyl-5-isopropyl-1,3-diazinane-2,4,6-trione\n| image = Enallylpropymal.png\n| width = 150\n| chirality = [[Racemic mixture]]\n| drug_name = \n<!--Clinical data-->\n| tradename =  \n| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->\n| pregnancy_US = <!-- A / B            / C / D / X -->\n| pregnancy_category =  \n| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->\n| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->\n| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->\n| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->\n| legal_status =  \n| routes_of_administration =\n\n<!--Pharmacokinetic data-->\n| bioavailability =  \n| protein_bound =  \n| metabolism =  \n| elimination_half-life =  \n| excretion =\n\n<!--Identifiers-->\n| CAS_number_Ref = {{cascite|correct|??}}\n| CAS_number = 1861-21-8\n| ATC_prefix = none\n| ATC_suffix =  \n| DrugBank_Ref = {{drugbankcite|correct|drugbank}}\n| DrugBank =  \n| ChemSpiderID = 86329\n\n<!--Chemical data-->\n| C=11 | H=16 | N=2 | O=3 \n| molecular_weight = 224.256 g/mol\n| smiles = O=C1NC(=O)N(C)C(=O)C1(C(C)C)CC=C\n| synonyms = Enallylpropymal\n|  PubChem = 95636\n|  StdInChI = 1S/C11H16N2O3/c1-5-6-11(7(2)3)8(14)12-10(16)13(4)9(11)15/h5,7H,1,6H2,2-4H3,(H,12,14,16)\n|  StdInChIKey = AXJXURWWUFZZKN-UHFFFAOYSA-N\n\n}}\n\n'''Enallylpropymal''' ('''Narconumal''') is a [[barbiturate]] derivative developed by Hoffman la Roche in the 1930s.<ref>US Patent 2072829</ref> It has [[sedative]] and [[hypnotic]] effects and is considered to have a moderate abuse potential.<ref>Eddy NB, Halbach H, Isbell H, Seevers MH. Drug dependence: Its significance and characteristics. ''Bulletin of the World Health Organization''. 1965;32:721-733.</ref>\n\n== References ==\n{{reflist}}\n\n{{Sedatives}}\n{{GABAAR PAMs}}\n\n[[Category:Barbiturates]]\n[[Category:Allyl compounds]]\n[[Category:GABAA receptor positive allosteric modulators]]\n\n\n{{sedative-stub}}\n", "name_user": "Fswitzer4", "label": "safe", "comment": "added FDA UNII to drug box", "url_page": "//en.wikipedia.org/wiki/Enallylpropymal"}
